loading page

Cyclic di-AMP affects cell membrane integrity of Streptococcus pneumoniae
  • +3
  • Tiffany M. Zarrella,
  • Jianle Gao,
  • Nathan Forrest,
  • Elijah Crosbourne,
  • Kaibo Cui,
  • Guangchun Bai
Tiffany M. Zarrella
Albany Medical College Department of Immunology and Microbial Disease
Author Profile
Jianle Gao
Albany Medical College Department of Immunology and Microbial Disease
Author Profile
Nathan Forrest
Albany Medical College Department of Immunology and Microbial Disease
Author Profile
Elijah Crosbourne
Albany Medical College Department of Immunology and Microbial Disease
Author Profile
Kaibo Cui
Albany Medical College Department of Immunology and Microbial Disease
Author Profile
Guangchun Bai
Albany Medical College Department of Immunology and Microbial Disease

Corresponding Author:baig@amc.edu

Author Profile

Abstract

Competence is an important bioprocess for Streptococcus pneumoniae. Previously, we demonstrated that bacterial second messenger cyclic di-adenosine monophosphate (c-di-AMP) modulates pneumococcal competence. Surprisingly, a low c-di-AMP-producing strain, cdaA*, due to a mutation in the diadenylate cyclase CdaA, is highly susceptible to competence-stimulating peptide (CSP). In this study, we screened cdaA* suppressor mutations resistant to CSP to explore c-di-AMP signaling in S. pneumoniae. A total of 14 clones were sequenced, nine clones possessed mutations in the c-di-AMP phosphodiesterase Pde1, indicating that the susceptibility to CSP of cdaA* is correlated to c-di-AMP levels. Another two clones exhibited a mutation in FabT, a transcription factor controlling cell membrane fatty acid biosynthesis and metabolism. We further showed that deletion of fabT, disruption of the FabT-binding site within the P fabK promoter, deletion of a fabT activator BriC, or disruption of K + uptake in cdaA* all rescued the growth defect of cdaA* in media supplemented with CSP. Finally, we found that a c-di-AMP phosphodiesterase-null mutant with high levels of c-di-AMP is highly sensitive to treatment with either ethanol or Triton X-100, which could be corrected by reducing c-di-AMP levels through introducing point mutations in CdaA. Together, these findings indicate that c-di-AMP affects cell membrane integrity.
01 Nov 2024Submitted to Molecular Microbiology
03 Nov 2024Submission Checks Completed
03 Nov 2024Assigned to Editor
04 Nov 2024Reviewer(s) Assigned
27 Nov 2024Review(s) Completed, Editorial Evaluation Pending
27 Nov 2024Editorial Decision: Revise Minor